Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer

Figure 1

Pharmacological response of resistant cell lines to aromatase inhibitors. Pharmacological response of MCF-7aro and Res-Ana cells to anastrozole (A) or letrozole (B) and of MCF-7aro and Res-Let cells to letrozole (C) or anastrozole (D), as assessed by cytotoxicity assays (mean ± SD from three independent experiments). *P < 0.05, **P < 0.01 and ***P < 0.001 versus the corresponding MCF-7aro (Student’s t-test).

Back to article page